These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 juni. The technology gains life-saving medical insights by analysing human excrement. Företaget har lämnat in en serie av tre patent som täcker delar av dess medicinska toalettsensor.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Europa, Japan och Kina.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, OutSenses teknologi kan identifiera källan till blod längs mag-tarmkanalen.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

Enligt OutSense vd Yfat Scialom, who predicts that “med explosionen av digital medicin, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, inflammatoriska tarmsjukdomar och urinvägsinfektioner.

Its solution consists of a multispectral optical sensor, en ljuskälla och en autonom avskärmningsenhet som inkluderar en WiFi-anslutning. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Information erhållen från blodprov, kombinerat med ytterligare analys av tiden från blödning till utsöndring, ger detaljer om blödningspatologin. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense meddelade att CommuniCare, ett stort sjukvårdsföretag med mer än 90 healthcare facilities in the US, kommer att börja testa sin teknik i år. Förutom denna pilot, OutSense also plans to conduct clinical trials in Israel and Japan.

Besök Fler nyheter på Viga.cc Nyheter